We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
10 Year Est. Return
AUM
$436M
AUM Growth
-$135M
Cap. Flow
-$140M
Cap. Flow %
-32.15%
Top 10 Hldgs %
4.96%
Holding
1,352
New
488
Increased
165
Reduced
221
Closed
478

Top Buys

Rank Stock Value
1
P
Everpure Inc
P
+$2.56M
2
CPB icon
Campbell Soup
CPB
+$2.06M
3
PD icon
PagerDuty
PD
+$1.97M
4
AVAV icon
AeroVironment
AVAV
+$1.71M
5
FULC icon
Fulcrum Therapeutics
FULC
+$1.69M

Top Sells

Rank Stock Value
1
TOL icon
Toll Brothers
TOL
+$3.62M
2
PATH icon
UiPath
PATH
+$2.98M
3
MAS icon
Masco
MAS
+$2.75M
4
PH icon
Parker-Hannifin
PH
+$2.7M
5
GGG icon
Graco
GGG
+$2.51M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Industrials 14.11%
3 Consumer Discretionary 13.81%
4 Healthcare 12.31%
5 Financials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRA icon
851
Vera Bradley
VRA
$96.4M
$79.3K 0.02%
+14,516
New +$85.7K
DFTX
852
Definium Therapeutics
DFTX
$5.99B
$78.7K 0.02%
+13,827
New +$96.2K
HL icon
853
Hecla Mining
HL
$11.8B
$76.7K 0.02%
11,493
-49,842
-81% -$291K
CIFR icon
854
Cipher Digital
CIFR
$6.78B
$75.7K 0.02%
19,553
-25,586
-57% -$108K
SCPH
855
DELISTED
scPharmaceuticals
SCPH
$70K 0.02%
15,349
-13,737
-47% -$66.4K
PYXS icon
856
Pyxis Oncology
PYXS
$243M
$69.3K 0.02%
+18,890
New +$66.1K
MRAM icon
857
Everspin Technologies
MRAM
$388M
$66.7K 0.02%
+11,298
New +$65.6K
BTBT icon
858
Bit Digital
BTBT
$454M
$63.3K 0.01%
+18,039
New +$59.9K
ATEC icon
859
Alphatec Holdings
ATEC
$1.47B
$62.7K 0.01%
+11,271
New +$86.5K
ALXO icon
860
ALX Oncology
ALXO
$285M
$62.6K 0.01%
34,373
+12,201
+55% +$45.4K
SOUN icon
861
SoundHound AI
SOUN
$3.25B
$59.1K 0.01%
+12,686
New +$61.3K
VERI icon
862
Veritone
VERI
$134M
$56.9K 0.01%
15,849
-13,866
-47% -$42.3K
AVAH icon
863
Aveanna Healthcare
AVAH
$2.06B
$53.7K 0.01%
+10,336
New +$46.7K
EEX
864
DELISTED
Emerald Holding
EEX
$53.3K 0.01%
+10,689
New +$57.2K
STTK icon
865
Shattuck Labs
STTK
$682M
$53.2K 0.01%
+15,245
New +$56.8K
WALD icon
866
Waldencast
WALD
$178M
$51.3K 0.01%
+14,104
New +$47.6K
SEAT icon
867
Vivid Seats
SEAT
$82.6M
$48.1K 0.01%
649
-551
-46% -$50.2K
OABI icon
868
OmniAb
OABI
$491M
$47.5K 0.01%
+11,225
New +$48.5K
MBI icon
869
MBIA
MBI
$256M
$45.5K 0.01%
+12,746
New +$52.7K
PRLD icon
870
Prelude Therapeutics
PRLD
$385M
$41.5K 0.01%
+20,048
New +$92.8K
VRCA icon
871
Verrica Pharmaceuticals
VRCA
$88M
$36.1K 0.01%
+2,487
New +$112K
PSTX
872
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$30.6K 0.01%
+10,696
New +$33.1K
SGMT icon
873
Sagimet Biosciences
SGMT
$591M
$27.9K 0.01%
10,073
-858
-8% -$2.65K
OM icon
874
Outset Medical
OM
$91.4M
$10.8K ﹤0.01%
+1,068
New +$31.8K
A icon
875
Agilent Technologies
A
$42B
-1,802
Closed -$234K

Similar funds

Sherbrooke Park Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, Sherbrooke Park Advisers held 1,352 positions worth $436M, down 24% from $571M the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Sherbrooke Park Advisers withdrew a net $140M in Q3 2024, closing 478 positions and reducing 221 holdings. Its most notable exit was Toll Brothers, an estimated $3.62M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Sherbrooke Park Advisers opened a new position in Everpure Inc worth $2.28M.

  • Sherbrooke Park Advisers's largest Q3 2024 buy was Everpure Inc: 45,326 shares worth $2.28M.
  • Sherbrooke Park Advisers added most to Smartsheet Inc. in Q3 2024, an estimated $1.57M increase.
  • Sherbrooke Park Advisers's biggest Q3 2024 reduction was Masco, cutting an estimated $2.75M.
  • Sherbrooke Park Advisers fully exited Toll Brothers in Q3 2024, selling an estimated $3.62M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5% of its $436M portfolio in Q3 2024.
  • Sherbrooke Park Advisers opened 488 new positions and closed 478 in Q3 2024.
  • Sherbrooke Park Advisers's portfolio value fell 24% quarter-over-quarter to $436M.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.